Periodic Reporting for period 3 - LSFM4LIFE (Production and characterization of endocrine cells derived from human pancreas organoids for the cell-based therapy of type 1 diabetes)

The worldwide incidence of type 1 diabetes (T1D) is increasing at a rate of 4% yearly. This alarming epidemiological data strongly motivates the development of a cellular treatment of T1D, in which the missing beta-cells are replenished with exogenous cells. Despite many...